# Calcitonin in the Treatment of Fibromyalgia

> **NCT00754884** · PHASE4 · WITHDRAWN · sponsor: **Unidad de Investigacion en Enfermedades Cronico-Degenerativas**

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** salmon calcitonin
- **DRUG:** intranasal saline solution plus glycerol

## Key facts

- **NCT ID:** NCT00754884
- **Lead sponsor:** Unidad de Investigacion en Enfermedades Cronico-Degenerativas
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study drug was not longer available in our country.
- **Last updated:** 2015-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00754884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00754884, "Calcitonin in the Treatment of Fibromyalgia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00754884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
